首页> 外文期刊>Research in Veterinary Science >In vitro efficacy of doxorubicin and etoposide against a feline injection site sarcoma cell line
【24h】

In vitro efficacy of doxorubicin and etoposide against a feline injection site sarcoma cell line

机译:阿霉素和依托泊苷对猫注射部位肉瘤细胞系的体外疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Feline injection site sarcoma (ISS) is a locally invasive tumor, in which surgical treatment is frequently combined with radiation or chemotherapy to improve tumor control. The focus of this study was to evaluate the cytotoxic effects of doxorubicin or etoposide on a feline injection site sarcoma cell line US) and to assess the impact of combining these drugs on cell death and cell cycle. Both single agent and combination drug administration increased cell death and significantly reduced the number of viable cells. Cells in G0/G1 were significantly reduced while the G2/M fraction was significantly increased following treatment. Collectively, combining doxorubicin and etoposide at the lower EC yielded comparable results to the EC50 of either drug alone in degree of cytotoxicity, level of apoptosis, and % of cells in G2/M. The results of this study indicate that doxorubicin and etoposide alone and in combination differentially alter ISS cell viability and cycle. (C) 2014 Elsevier Ltd. All rights reserved.
机译:猫注射部位肉瘤(ISS)是一种局部侵袭性肿瘤,其中外科治疗经常与放疗或化学疗法结合以改善肿瘤控制。这项研究的重点是评估阿霉素或依托泊苷对猫注射部位肉瘤细胞系US的细胞毒性作用,并评估组合这些药物对细胞死亡和细胞周期的影响。单一药剂和组合药物的施用均增加了细胞死亡并显着减少了活细胞的数量。处理后,G0 / G1细胞显着减少,而G2 / M分数显着增加。总的来说,在较低的EC浓度下将阿霉素和依托泊苷联合使用,在细胞毒性程度,细胞凋亡水平和G2 / M细胞百分比方面,可与两种药物单独使用的EC50值相媲美。这项研究的结果表明,阿霉素和依托泊苷单独使用或与依托泊苷联合使用都可以不同地改变ISS细胞的活力和周期。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号